Skip to content

Proof-of-concept Lymfif

A Proof-of-concept Study of Lymfit: A Personalized, Virtual Exercise Intervention to Improve Health Outcomes in Lymphoma Survivors in the Pandemic

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05546489
Acronym
QI_LF
Enrollment
20
Registered
2022-09-19
Start date
2021-05-01
Completion date
2022-02-01
Last updated
2022-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of Life

Keywords

Quality of Life, cancer survivors

Brief summary

This proof-of-concept study was to explore the implementation feasibility to deliver the Lymfit intervention to participants remotely during the pandemic.

Interventions

Wearable activity trackers (Fitbit) were given to participants as a motivational tool and for data collection purposes. Participants received a personalized exercise prescription designed by a kinesiologist. Physiologic metrics were collected by the Fitbit monitors and were stored in the Lymfit database. Self-reported questionnaires measuring health outcomes were collected at baseline and post-intervention.

Sponsors

McGill University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 1\. previously diagnosed with lymphoma * 2\. have completed chemotherapy * 3\. had access to a smart phone or an electronic device (e.g., tablet) that allowed them to attend virtual meetings and install the Fitbit application

Exclusion criteria

-1. have any contra-indications to performing physical activities as determined by the hematologist

Design outcomes

Primary

MeasureTime frameDescription
Quality of Life : changes from baseline to post-intervention12 weeksPatient-Reported Outcomes Measurement Information System 29 items The scale has 29 items which measure perceived health status along 7 domains (physical function, anxiety, depressive symptoms, fatigue, sleep disturbance, ability to participate in social roles and activities, and pain interference), with items answered on five-point Likert scales. Raw scores generated for each domain will be transformed into a T score. The T score range from -0.022 to 1.0, with higher scores indicating greater endorsement of the construct being assessed.

Secondary

MeasureTime frameDescription
Fear of Cancer Recurrence : changes from baseline to post-intervention12 weeksFear of Cancer Recurrence Inventory 42 items
Fear related to the pandemic : changes from baseline to post-intervention12 weeksthe Fear of 2019 coronavirus disease (COVID) scale 7 items The items are rated on a five-point Likert scale ranging from strongly disagree (1) to strongly agree (5) with total scores ranging from 7 to 35. Higher total scores represent higher levels of fear.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026